Citation 83053

KATO,A: ADACHI,I: MIYAUCHI,M: IKEDA,K: KOMAE,T: KIZU,H: KAMEDA,Y: WATSON,AA: NASH,RJ: WORMALD,MR: FLEET,GWJ: ASANO,N:. (1999). POLYHYDROXYLATED PYRROLIDINE AND PYRROLIZIDINE ALKALOIDS FROM HYACINTHOIDES NON-SCRIPTA AND SCILLA CAMPANULATA.. 316(1-4)

Citation Details

Title	POLYHYDROXYLATED PYRROLIDINE AND PYRROLIZIDINE ALKALOIDS FROM HYACINTHOIDES NON-SCRIPTA AND SCILLA CAMPANULATA.
Authors	KATO,A: ADACHI,I: MIYAUCHI,M: IKEDA,K: KOMAE,T: KIZU,H: KAMEDA,Y: WATSON,AA: NASH,RJ: WORMALD,MR: FLEET,GWJ: ASANO,N:
Year	1999
Volume	316
Issue	1-4

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (2)

Hyacinthoides non-scripta (LILIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARABINITOL,D: 1-4-DIDEOXY-14-IMINO:	None
2	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ARABINITOL,D: 1-4-DIDEOXY-14-IMINO:	ACTIVE
3	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PYRROLIDINE,3(R)-4(R)-DIHYDROXY: 2(R)-5(R)-BIS(HYDROXY-METHYL):	None
4	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PYRROLIDINE,3(R)-4(R)-DIHYDROXY: 2(R)-5(R)-BIS(HYDROXY-METHYL):	ACTIVE
5	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO: 6-DEOXY-6-C-(2-5-DIHYDROXY-HEXYL):	None
6	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO: 6-DEOXY-6-C-(2-5-DIHYDROXY-HEXYL):	EQUIVOCAL
7	MALTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO: 6-DEOXY-6-C-(2-5-DIHYDROXY-HEXYL):	EQUIVOCAL
8	BETA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO: 6-DEOXY-6-C-(2-5-DIHYDROXY-HEXYL):	EQUIVOCAL
9	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO: 6-DEOXY-6-C-(2-5-DIHYDROXY-HEXYL):	EQUIVOCAL
10	LACTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO: 6-DEOXY-6-C-(2-5-DIHYDROXY-HEXYL):	EQUIVOCAL
11	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO: 6-DEOXY-6-C-(2-5-DIHYDROXY-HEXYL):	EQUIVOCAL
12	TREHALASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO: 6-DEOXY-6-C-(2-5-DIHYDROXY-HEXYL):	EQUIVOCAL
13	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO: 6-DEOXY-6-C-(2-5-DIHYDROXY-HEXYL):	ACTIVE
14	AMYLOGLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO: 6-DEOXY-6-C-(2-5-DIHYDROXY-HEXYL):	ACTIVE
15	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO:	None
16	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO:	ACTIVE
17	MALTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO:	ACTIVE
18	BETA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO:	ACTIVE
19	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO:	ACTIVE
20	LACTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO:	ACTIVE
21	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO:	ACTIVE
22	TREHALASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO:	ACTIVE
23	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO:	EQUIVOCAL
24	AMYLOGLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DI-GLYCERO:	ACTIVE
25	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-APIOSIDE	None
26	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-APIOSIDE	EQUIVOCAL
27	MALTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-APIOSIDE	EQUIVOCAL
28	BETA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-APIOSIDE	EQUIVOCAL
29	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-APIOSIDE	ACTIVE
30	LACTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-APIOSIDE	ACTIVE
31	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-APIOSIDE	EQUIVOCAL
32	TREHALASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-APIOSIDE	EQUIVOCAL
33	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-APIOSIDE	EQUIVOCAL
34	AMYLOGLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-APIOSIDE	ACTIVE
35	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-BETA-D-XYLOPYRANOSIDE:	None
36	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-BETA-D-XYLOPYRANOSIDE:	EQUIVOCAL
37	MALTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-BETA-D-XYLOPYRANOSIDE:	EQUIVOCAL
38	BETA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-BETA-D-XYLOPYRANOSIDE:	ACTIVE
39	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-BETA-D-XYLOPYRANOSIDE:	ACTIVE
40	LACTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-BETA-D-XYLOPYRANOSIDE:	ACTIVE
41	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-BETA-D-XYLOPYRANOSIDE:	ACTIVE
42	TREHALASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-BETA-D-XYLOPYRANOSIDE:	EQUIVOCAL
43	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-BETA-D-XYLOPYRANOSIDE:	EQUIVOCAL
44	AMYLOGLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-BETA-D-XYLOPYRANOSIDE:	ACTIVE
45	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HYACINTHACINE B-1	None
46	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE B-1	EQUIVOCAL
47	MALTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE B-1	EQUIVOCAL
48	BETA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE B-1	ACTIVE
49	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE B-1	ACTIVE
50	LACTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE B-1	ACTIVE
51	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE B-1	EQUIVOCAL
52	TREHALASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE B-1	EQUIVOCAL
53	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE B-1	EQUIVOCAL
54	AMYLOGLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE B-1	EQUIVOCAL
55	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HYACINTHACINE C-1	None
56	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE C-1	EQUIVOCAL
57	MALTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE C-1	EQUIVOCAL
58	BETA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE C-1	EQUIVOCAL
59	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE C-1	EQUIVOCAL
60	LACTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE C-1	EQUIVOCAL
61	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE C-1	EQUIVOCAL
62	TREHALASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE C-1	EQUIVOCAL
63	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE C-1	EQUIVOCAL
64	AMYLOGLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE C-1	ACTIVE

Scilla campanulata (LILIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	ARABINITOL,D: 1-4-DIDEOXY-1-4-IMINO:	None
2	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HYACINTHACINE B-2	None
3	ALPHA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE B-2	EQUIVOCAL
4	MALTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE B-2	EQUIVOCAL
5	BETA-GLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE B-2	ACTIVE
6	BETA-GALACTOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE B-2	ACTIVE
7	LACTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE B-2	ACTIVE
8	BETA-MANNOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE B-2	EQUIVOCAL
9	TREHALASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE B-2	EQUIVOCAL
10	MISCELLANEOUS EFFECTS	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE B-2	EQUIVOCAL
11	AMYLOGLUCOSIDASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HYACINTHACINE B-2	EQUIVOCAL
12	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	PYRROLIDINE,3(R)-4(R)-DIHYDROXY: 2(R)-5(R)-BIS(HYDROXY-METHYL):	None
13	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 6-DEOXY-6-C-(2-5-DIHYDROXY-HEXYL):	None
14	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO:	None
15	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HEPTITOL,D-MANNO: 2-5-DIDEOXY-2-5-IMINO-DL-GLYCERO: 7-O-APIOSIDE	None
16	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	HYACINTHACINE B-1	None